Fredun Pharmaceuticals Statistics

Total Valuation

BOM:539730 has a market cap or net worth of INR 3.43 billion. The enterprise value is 5.04 billion.

Market Cap	3.43B
Enterprise Value	5.04B

Important Dates

The last earnings date was Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:539730 has 4.70 million shares outstanding. The number of shares has decreased by -5.15% in one year.

Current Share Class	4.70M
Shares Outstanding	4.70M
Shares Change (YoY)	-5.15%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	56.84%
Owned by Institutions (%)	1.60%
Float	2.03M

Valuation Ratios

The trailing PE ratio is 16.26.

PE Ratio	16.26
Forward PE	n/a
PS Ratio	0.75
PB Ratio	2.42
P/TBV Ratio	2.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.17, with an EV/FCF ratio of -14.32.

EV / Earnings	25.52
EV / Sales	1.10
EV / EBITDA	9.17
EV / EBIT	10.10
EV / FCF	-14.32

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 1.18.

Current Ratio	1.33
Quick Ratio	0.57
Debt / Equity	1.18
Debt / EBITDA	3.04
Debt / FCF	-4.75
Interest Coverage	2.23

Financial Efficiency

Return on equity (ROE) is 15.02% and return on invested capital (ROIC) is 11.64%.

Return on Equity (ROE)	15.02%
Return on Assets (ROA)	7.84%
Return on Invested Capital (ROIC)	11.64%
Return on Capital Employed (ROCE)	30.00%
Revenue Per Employee	17.82M
Profits Per Employee	771,066
Employee Count	256
Asset Turnover	1.15
Inventory Turnover	1.68

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.32% in the last 52 weeks. The beta is 0.85, so BOM:539730's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-10.32%
50-Day Moving Average	703.15
200-Day Moving Average	723.91
Relative Strength Index (RSI)	52.40
Average Volume (20 Days)	13,769

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:539730 had revenue of INR 4.56 billion and earned 197.39 million in profits. Earnings per share was 44.83.

Revenue	4.56B
Gross Profit	1.09B
Operating Income	498.70M
Pretax Income	274.94M
Net Income	197.39M
EBITDA	549.10M
EBIT	498.70M
Earnings Per Share (EPS)	44.83

Full Income Statement

Balance Sheet

The company has 59.73 million in cash and 1.67 billion in debt, giving a net cash position of -1.61 billion or -342.98 per share.

Cash & Cash Equivalents	59.73M
Total Debt	1.67B
Net Cash	-1.61B
Net Cash Per Share	-342.98
Equity (Book Value)	1.41B
Book Value Per Share	321.09
Working Capital	1.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -290.63 million and capital expenditures -61.06 million, giving a free cash flow of -351.69 million.

Operating Cash Flow	-290.63M
Capital Expenditures	-61.06M
Free Cash Flow	-351.69M
FCF Per Share	-74.84

Full Cash Flow Statement

Margins

Gross margin is 23.82%, with operating and profit margins of 10.93% and 4.33%.

Gross Margin	23.82%
Operating Margin	10.93%
Pretax Margin	6.03%
Profit Margin	4.33%
EBITDA Margin	12.03%
EBIT Margin	10.93%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 0.10%.

Dividend Per Share	0.70
Dividend Yield	0.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.15%
Shareholder Yield	5.24%
Earnings Yield	5.76%
FCF Yield	-10.27%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a